We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

63 hedge funds and large institutions have $27.5M invested in Enzo Biochem, Inc. in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less call options, than puts

Call options by funds: $5K | Put options by funds: $59K

Holders
63
Holders Change
+63
Holders Change %
–
% of All Funds
2.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
63
Increased
–
Reduced
–
Closed
–
Calls
$5K
Puts
$59K
Net Calls
-$54K
Net Calls Change
-$54K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$6.96M +$7.39M +3,348,029 New
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$4.12M +$4.37M +1,981,453 New
Millennium Management
3
Millennium Management
New York
$3.14M +$3.33M +1,510,000 New
ClearBridge Investments
4
ClearBridge Investments
New York
$2.67M +$2.83M +1,282,042 New
BIT
5
BlackRock Institutional Trust
California
$1.8M +$1.91M +866,960 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.52M +$1.62M +732,721 New
CCM
7
Corsair Capital Management
New York
$1.13M +$1.2M +545,077 New
Renaissance Technologies
8
Renaissance Technologies
New York
$538K +$571K +258,500 New
CCT
9
Chemung Canal Trust
New York
$519K +$551K +249,434 New
BCM
10
Bridgeway Capital Management
Texas
$500K +$530K +240,200 New
LMF
11
LMR Master Fund
Cayman Islands
$416K +$441K +200,000 New
Goldman Sachs
12
Goldman Sachs
New York
$352K +$373K +169,211 New
New York State Teachers Retirement System (NYSTRS)
13
New York State Teachers Retirement System (NYSTRS)
New York
$268K +$284K +128,652 New
Ameriprise
14
Ameriprise
Minnesota
$260K +$275K +124,601 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$260K +$276K +125,157 New
Northern Trust
16
Northern Trust
Illinois
$234K +$249K +112,626 New
APU
17
Alpine Partners USVI
U.S. Virgin Islands
$230K +$245K +110,810 New
Morgan Stanley
18
Morgan Stanley
New York
$217K +$231K +104,461 New
CFB
19
Cullen/Frost Bankers
Texas
$214K +$227K +102,772 New
BFA
20
BlackRock Fund Advisors
California
$186K +$198K +89,491 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$180K +$191K +86,628 New
Charles Schwab
22
Charles Schwab
California
$168K +$174K +78,781 New
GCP
23
GSA Capital Partners
United Kingdom
$150K +$159K +72,193 New
KCM
24
Kempner Capital Management
Texas
$146K +$155K +70,001 New
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$135K +$143K +64,800 New
1
2 3

ENZ Hedge Fund Activity: Q2 2013 in Review

63 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2013, worth a combined $27.5M.

Buyers outnumbered sellers: 63 funds opened new ENZ positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.

  • 63 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $27.5M of Enzo Biochem, Inc. stock for Q2 2013.
  • 63 funds opened new Enzo Biochem, Inc. positions in Q2 2013 and 0 closed out, a net change of +63 holders.

Based on aggregated 13F filings for Q2 2013.